Displaying 1 - 12 of 12
Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Current understanding of adult-onset PFIC

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Ipsen: Shining a light on unexplained cholestasis (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Genetic variants associated with cholestasis in adult clinical practice

Webcasts
View
Immune-Mediated and Cholestatic Diseases

The challenge of clinically diagnosing adult-onset PFIC: A patient case

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Building management strategies for adult-onset PFIC

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

PFIC in practice: Paediatric and adult case studies of patients with idiopathic cholestasis

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Challenges in the Management of Patients with Cholestatic Liver Diseases

Webcasts
View
Displaying 1 - 12 of 12